Search

Your search keyword '"Olli, Vapalahti"' showing total 547 results

Search Constraints

Start Over You searched for: Author "Olli, Vapalahti" Remove constraint Author: "Olli, Vapalahti"
547 results on '"Olli, Vapalahti"'

Search Results

501. Effect of interferon-alpha and cell differentiation on Puumala virus infection in human monocyte/macrophages

502. Hantavirus infections in Europe — Authors' reply

503. Sequences of wild Puumala virus genes show a correlation of genetic variation with geographic origin of the strains

504. Intracerebral Borna Disease Virus Infection of Bank Voles Leading to Peripheral Spread and Reverse Transcription of Viral RNA

505. Susceptibility of human cells to Puumala virus infection

506. 374 Tick-borne encephalitis virus proteins PRM and NS1 act as potent inhibitors of cytokine gene expression

507. Genetic analysis of hantaviruses carried by Myodes and Microtus rodents in Buryatia

508. Bioportfolio: lifelong tissue persistence of new and old parvoviruses

509. Dobrava hantavirus in Estonia: does the virus exist throughout Europe?

510. How many kinds of hantaviruses?

511. Hantavirus antibodies in European mammalogists

512. Serological Evidence of Viruses Naturally Associated with the Montane Water Vole (Arvicola scherman) in Eastern France.

513. Diagnostics of Pogosta Disease Antigenic Properties and Evaluation of Sindbis Virus IgM and IgG Enzyme Immunoassays.

514. Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon‐beta promoter.

516. Incidence Trends for SARS-CoV-2 Alpha and Beta Variants, Finland, Spring 2021

517. Development of a high-throughput colorimetric Zika virus infection assay

518. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: A two-year follow-up study

519. Renal function and blood pressure five years after Puumala virus-induced nephropathy

520. Antigenic properties and diagnostic potential of puumala virus nucleocapsid protein expressed in insect cells

522. Hypophyseal hemorrhage and panhypopituitarism during puumala virus infection: Magnetic resonance imaging and detection of viral antigen in the hypophysis

523. Puumala virus infections in Finland: Increased occupational risk for farmers

524. Intranasal inhibitor broadly blocks SARS-CoV-2 including recent highly immunoevasive Omicron subvariants

525. Recent expansion of dengue virus serotype 3 in West Africa

527. COVID-19-tutkimuskatsaus 8/2021

528. Puumala virus antibody and immunoglobulin G avidity assays based on a recombinant nucleocapsid antigen

530. HUMAN B-CELL EPITOPES OF PUUMALA VIRUS NUCLEOCAPSID PROTEIN, THE MAJOR ANTIGEN IN EARLY SEROLOGICAL RESPONSE

532. ClusTRace, a bioinformatic pipeline for analyzing clusters in virus phylogenies

533. Causative agent of pogosta disease isolated from blood and skin lesions

534. Taxonomy of the family Arenaviridae and the order Bunyavirales: update 2018

535. Isolation and characterization of Dobrava hantavirus carried by the striped field mouse (Apodemus agrarius) in Estonia

536. First report of Ixodes frontalis (Acari: Ixodidae) in Finland, an example of foreign tick species transported by a migratory bird

537. COVID-19-tutkimuskatsaus 6/2021

539. Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae

540. Experimental investigation of a hantavirus host-switch between arvicoline rodents Lemmus lemmus and Myodes glareolus

541. Systemic inflammation in hemorrhagic fever with renal syndrome correlates with hypotension and thrombocytopenia but not with renal injury

542. SARS-CoV-2 and Type 1 Diabetes in Finnish Children

543. The clinical severity of Puumala hantavirus-induced nephropathia epidemica and partial complement protein C4 deficiencies

544. Clinical Sindbis alphavirus infection is associated with HLA-DRB1*01 allele and production of autoantibodies

545. Survey of selected tick-borne diseases in dogs in Finland

546. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

547. Evolutionary trends of European bat lyssavirus type 2 including genetic characterization of Finnish strains of human and bat origin 24 years apart.

Catalog

Books, media, physical & digital resources